Manufacturing countries

Where pharmaceutical manufacturing sites are

Physical locations of drug establishments registered with the US FDA: 9,848 sites in the 36 countries below (each with at least five published sites), 2,388 of them registered for API manufacture. Countries with fewer sites are counted in the open dataset. Country is the site address, not the owner's headquarters. Sites serving only non-US markets are not in this register, so these are US-facing counts, not global capacity.

Looking for companies by headquarters instead? See the company directory.

CountryFDA-registered sitesAPI manufactureIdentified registrantsSites with current EU/UK GMP match
India1,043554667191
United States5,3945133,05262
China1,1395121,00284
Italy18090118139
Germany24885187159
Japan1488410233
France19264141103
Spain1435811175
United Kingdom1504211383
South Korea155411411
Switzerland110418575
Canada205341751
Ireland79346051
Netherlands50233839
Mexico8922801
Israel44203619
Denmark32202126
Taiwan5717524
Belgium48163928
Austria35142424
Singapore32122610
Brazil3011273
Czech Republic25101915
Hungary111093
Sweden2691720
Argentina159146
Poland208175
Australia386360
Turkey335310
Finland17599
South Africa11592
Norway8553
Portugal183159
Malta7366
Romania6256
Greece101106

Countries with at least five published sites. Source: FDA Drug Establishments Current Registration Site; GMP matches from EudraGMDP and MHRA GMDP. Methodology · download this table

Published sites in other countries

Countries with fewer than five published sites have no dashboard; their 49 sites are listed here.

Bangladesh

Bulgaria

Chile

Congo - Brazzaville

Costa Rica

Croatia

Dominican Republic

Estonia

Hong Kong

Iceland

Latvia

Lithuania

Macau

Malaysia

New Zealand

Oman

Paraguay

Puerto Rico

Rwanda

Serbia

Slovakia

Slovenia

Thailand